Eagle Pharmaceuticals, Inc. Operating Lease Right-of-Use Assets
Eagle Pharmaceuticals, Inc. had Operating Lease Right-of-Use Assets of $3.58 million as of 2020-09-30, per its 10-Q filed 2020-11-02.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2020-11-02
- 2020-09-30: Operating Lease, Right-of-Use Asset $3.58M.
- 2020-06-30: Operating Lease, Right-of-Use Asset $4.09M.
- 2020-03-31: Operating Lease, Right-of-Use Asset $4.34M.
- 2019-12-31: Operating Lease, Right-of-Use Asset $3.72M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2020-09-30 | $3.58M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $4.09M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $4.34M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $3.72M 10-Q · filed 2020-11-02 |
| 2019-09-30 | $4.18M 10-Q · filed 2020-11-02 |
| 2019-06-30 | $2.48M 10-Q · filed 2020-08-10 |
| 2019-03-31 | $2.87M 10-Q · filed 2020-05-11 |